Literature DB >> 1826532

Prediction of the renal clearance of cimetidine using endogenous N-1-methylnicotinamide.

A Maiza1, P T Daley-Yates.   

Abstract

We investigated the influence of the type rather than the degree of renal insufficiency on the renal clearance of drugs. Different models of site specific experimental renal failure (ERF) have been developed in the rat; proximal tubular necrosis, induced by cisplatin; papillary necrosis, induced by 2-bromoethylamine, and glomerulonephritis, induced by sodium aurothiomalate or by antiglomerular basement membrane antibody. Several parameters of kidney function were assessed: the clearance of inulin, PAH, and endogenous N-1-methylnicotinamide (NMN). Plasma BUN and creatinine concentrations, and the presence of proteinuria and glucosuria were also measured. Our results showed a nonparallel decrease in glomerular filtration rate (GFR) and tubular secretion as measured by the secretory clearance of endogenous NMN or by the secretory clearance of p-aminohippuric acid (PAH), that is incompatible with the "intact nephron hypothesis." As a result, the renal clearance of cimetidine, a drug eliminated mainly by renal secretion, correlated better with the renal clearance of endogenous NMN than with the GFR. We conclude that (i) our models of ERF demonstrated the existence of glomerulo-tubular imbalance that is contrary to expectations based on the intact nephron hypothesis; (ii) the type of the renal disease has a direct influence on the renal clearance of cimetidine; (iii) the clearance of endogenous NMN may be a valuable noninvasive test for assessing renal tubular secretion which could be useful in predicting the clearance of drugs eliminated predominantly by tubular secretion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826532     DOI: 10.1007/bf01073868

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  33 in total

Review 1.  Use of serum creatinine concentrations to determine renal function.

Authors:  T D Bjornsson
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

2.  Characterization and isolation of specific renal tubular epithelial antigens.

Authors:  T S Edgington; R J Glassock; J I Watson; F J Dixon
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

3.  Micropuncture study in rats with experimental glomerulonephritis.

Authors:  A Rocha; M Marcondes; G Malnic
Journal:  Kidney Int       Date:  1973-01       Impact factor: 10.612

4.  A study by micropuncture and microdissection of acute renal damage in rats.

Authors:  T U Biber; M Mylle; A D Baines; C W Gottschalk; J R Oliver; M C MacDowell
Journal:  Am J Med       Date:  1968-05       Impact factor: 4.965

5.  Gold nephropathy in rats--light and electron microscopic studies.

Authors:  A H Nagi; F Alexander; A Z Barabas
Journal:  Exp Mol Pathol       Date:  1971-12       Impact factor: 3.362

Review 6.  Drug dosage in renal disease.

Authors:  L Dettli
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

7.  Aging and renal clearance of procainamide and acetylprocainamide.

Authors:  M M Reidenberg; M Camacho; J Kluger; D E Drayer
Journal:  Clin Pharmacol Ther       Date:  1980-12       Impact factor: 6.875

8.  Renal function studies in an experimental model of papillary necrosis in the rat.

Authors:  R Vanholder; N Lameire; W Eeckhaut; S Ringoir
Journal:  Arch Int Physiol Biochim       Date:  1981-02

9.  Estimation of renal blood flow by use of endogenous N1-methylnicotinamide in rats.

Authors:  C K Shim; Y Sawada; T Iga; M Hanano
Journal:  J Pharmacobiodyn       Date:  1985-01

10.  Renal excretion of cimetidine.

Authors:  I M Weiner; L Roth
Journal:  J Pharmacol Exp Ther       Date:  1981-03       Impact factor: 4.030

View more
  5 in total

1.  Renal excretion of apricitabine in rats: ex vivo and in vivo studies.

Authors:  Mariana Babayeva; Susan Cox; Michael P White; David R Taft
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-04-06       Impact factor: 2.441

2.  A general empirical model for renal drug handling in pharmacokinetic analyses.

Authors:  Daniel F B Wright; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2017-05-10       Impact factor: 4.335

3.  Impaired Tubular Secretion of Organic Solutes in Acute Kidney Injury.

Authors:  Frank J O'Brien; Robert D Mair; Natalie S Plummer; Timothy W Meyer; Scott M Sutherland; Tammy L Sirich
Journal:  Kidney360       Date:  2020-08-27

4.  Effect of dronedarone on renal function in healthy subjects.

Authors:  Yvonne Tschuppert; Thierry Buclin; Laura E Rothuizen; Laurent A Decosterd; Jacques Galleyrand; Christine Gaud; Jérôme Biollaz
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335

5.  Variability in the renal clearance of cephalexin in experimental renal failure.

Authors:  A Maïza; P T Daley-Yates
Journal:  J Pharmacokinet Biopharm       Date:  1993-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.